We are grateful to partner with and support patient advocacy groups and programs that are aligned with our focus to improve the needs of people with neurological conditions.
Currently, we are raising seed funding (3 million) so we can complete our IND enable studies.
To learn more, please contact us.
362 West Huron Street, Chicago, Illinois 60654, United States
Progenicyte Therapeutics, Inc.
362 West Huron Street, Chicago, Illinois 60654, United States
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.